Concerns Rise Over Safety of Lab-Grown Blood Vessel
The Food and Drug Administration office in White Oak, Maryland.
Photographer: Sarah Silbiger/Getty ImagesThis article is for subscribers only.
Hi, it’s Anna in Virginia. A month ago I wrote about a whistleblower who said FDA staff were pressured to approve a medical device. This wasn’t the end of the story, but before we get to that ...
Symvess, a Humacyte product, was approved by the Food and Drug Administration in December to help save limbs after severe trauma, whether it’s on the battlefield or in hospitals around the US.